EAP and ECPCP urge ban on novel nicotine‐ (NNCPS) and non‐nicotine‐containing products (NNDS) to youth

Abstract

AbstractAimWe want to verify the correlation between the increasing use of novel nicotine‐containing products (NNCPs) and non‐nicotine delivery products (NNDPs) among young individuals and the escalating negative health consequences, necessitating their prohibition.MethodsWe performed a comprehensive analysis of the most relevant literature about the utilisation of NNCPs and NNDPs among young individuals and their health effects.ResultsDespite being initially seen as less harmful alternatives, for smokers aiming to quit, these products have become more popular due to misleading marketing claims. Teenagers using NNCPs and NNDPs, despite having no smoking history, are more likely to transition to tobacco smoking. Consistent use can lead to health issues like pulmonary damage, asthma, and cardiovascular and ocular problems.ConclusionThe EAP and the ECPCP endorse the WHO's appeal to outlaw these hazardous products. They urge European governments to forbid the sale of NNCPs and NNDPs to children and adolescents in order to safeguard their well‐being. They also propose specific recommendations (box 4) to support this cause.